Skip to main content


at San Francisco, California and other locations
study started
estimated completion:



Clinical, diagnostic, and therapeutic data specific for primary spinal column tumor patients will be collected and evaluated to investigate the prognostic factors which influence survival, local recurrence, adverse events, perioperative morbidity, and HRQOL in subgroups of patients diagnosed with primary spinal column tumors.

Official Title

Primary Tumor Research and Outcome Network (PTRON) A Multicenter Prospective Registry for the Management of Primary Tumors of the Spine


Objective: To prospectively investigate the prognostic variables (clinical, diagnostic, and therapeutic) within subgroups of patients diagnosed with primary spinal column tumors that are associated with:

  • survival
  • local recurrence
  • perioperative morbidity
  • patient reported outcomes

Outcome measures: Variables applicable to primary spinal coumn tumor patients which will be collected in the registry include:

  • Patient details
  • Treatment status
  • Details of previous treatment
  • Diagnosis and biopsy types
  • Tumor details
  • Oncological staging
  • Symptoms
  • Treatment details
  • Imaging information

The investigators aim to collect the following outcome measures:

  • Overall survival data
  • Local disease recurrence data
  • Perioperative morbidity data

Patient reported outcomes:

  • Euroqual-5D-3L
  • Euroquol EQ-5D VAS - Quality of Life
  • Neck pain numeric rating scale (NRS)
  • Arm pain NRS
  • Back pain NRS
  • Leg Pain NRS
  • SF-36 version 2
  • SOSG Outcome Questionnaire


Spinal Cord Tumor Registry Spine Surgery Medical Oncology Radiation Oncology Neoplasms


You can join if…

  • Patient diagnosed with a primary tumor of the spine who receive medical and/or surgical treatment for the tumor.
  • Patient willing and able to participate in the registry and able to attend follow-up visits, according to the investigator.
  • Patient capable of understanding the content of the patient information and Informed Consent Form (if consent is required by the EC/ IRB at the registry site).
  • Patient who has agreed to participate in the registry by providing consent according to the applicable local law and the declaration of Helsinki.

You CAN'T join if...

  • Patient diagnosed with a metastatic tumor of the spine.
  • Patient diagnosed with a primary spinal cord tumor.


  • Vancouver General Hospital and the University of British Columbia accepting new patients
    Vancouver, British Columbia, V5Z 1M9, Canada
  • The University of Texas M.D. Anderson Cancer Center not yet accepting patients
    Houston, Texas, 77030, United States
  • Mayo Clinic accepting new patients
    Rochester, Minnesota, 55905, United States
  • Univerity of Toronto not yet accepting patients
    Toronto, Ontario, M5T 2S8, Canada
  • Johns Hopkins University School of Medicine not yet accepting patients
    Baltimore, Maryland, MD 21205, United States
  • Memorial Sloan-Kettering Cancer Center not yet accepting patients
    New York, New York, NY 10065, United States
  • Rhode Island Hospital not yet accepting patients
    Providence, Rhode Island, 02903, United States
  • Oxford University Hospitals not yet accepting patients
    Oxford, OX3 7HE, United Kingdom
  • Kanazawa Medical University Hospital not yet accepting patients
    Kanazawa, 920-8641, Japan
  • Universitaetsklinikum Carl Gustav Carus der Techn. Universitaet - Dresden not yet accepting patients
    Dresden, 1307, Germany
  • National Center for Spinal Disorders and Buda Health Center not yet accepting patients
    Budapest, 1126, Hungary
  • Istituto Ortopedico Rizzoli not yet accepting patients
    Bologna, 40136, Italy
  • IRCCS Istituto Ortopedico Galeazzi not yet accepting patients
    Milano, 20161, Italy
  • University of Queensland, School of Medicine not yet accepting patients
    Brisbane, 4000 QLD, Australia


accepting new patients
Start Date
Completion Date
AO Clinical Investigation and Documentation
Study Type
Observational [Patient Registry]
Last Updated
November 1, 2016
I’m interested in this study!